REG - Vulcan Two Group PLC - Board Update

Vulcan TwoAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260112:nRSL4886Oa&default-theme=true

RNS Number : 4886O  Vulcan Two Group PLC  12 January 2026

12 January 2026

 Vulcan Two Group plc

(the "Company" or "Vulcan Two")

 

Board Update

 

Vulcan Two Group plc, the company aiming to create the UK's leading regulated
ePharmacy through buy-and-build, announces that the Company's Chief Financial
Officer ("CFO"), Simon Carter, has decided to step down from the Board and
from his position as CFO for personal reasons, with immediate effect. Simon
will continue to work with the Company, taking a new role in the finance team.

 

The Company is delighted to announce that Keith Butcher, the former CFO of,
inter alia, Boku Inc. and Paysafe, has been appointed in an interim role as
CFO for a period of at least 6 months. Keith is a highly experienced CFO with
over 20 years as a publicly listed LSE Finance Director. He brings a
considerable track record of success in delivering transformational
acquisitions and in creating shareholder value in technology-based e-commerce
businesses.

 

It is expected that Keith will join the Board if the Company completes its
inaugural acquisition during the period of his employment. Any such
appointment would be subject to the completion of customary due diligence by
the Company's advisers.

 

The Board is also delighted to announce the appointment of Dr David Wong as a
Non-Executive Director, who brings significant experience in healthcare,
capital markets and public company boards. David is the co-founder of Reset
Health, an integrated chronic care specialist delivering best in class
scalable doctor-led digital solutions for patients. He is also the founder of
Medical Consultant and Management Capital, a specialist strategic advisory
boutique and investor. David has over 40 years' experience serving on the
boards of UK-listed companies, including Slater Foods plc, MDY Healthcare plc,
Triple Arc plc and Galleon Holdings plc.

 

Michael Kraftman, Chief Executive Officer of Vulcan Two, commented: "We are
delighted to welcome a CFO of Keith's calibre to Vulcan Two. His considerable
experience in transformational acquisitions and delivering shareholder value
will be invaluable as we progress our buy-and-build strategy.

 

"We are also pleased to welcome David to the Board as a Non-Executive
Director, who brings real domain expertise and insight into the ePharmacy
industry."

 

Susan Clement Davies, Chair of Vulcan Two, added: "The Company is pleased to
welcome Keith and David at an important stage in Vulcan Two's development as a
public company. Keith brings deep financial and listed-company experience, and
David adds valuable perspective from across healthcare. Together, these
appointments further strengthen and support the Company's next phase of
development."

 

Dr. David Chee Wai Wong, aged 72, holds the following
directorships/partnerships:

Beach8 Limited

Reset Health Ltd

Reset Health Clinics Limited

Reset Academy of Metabolic Sciences Ltd

Roczen Ltd

Autonomyx Ltd

Emagine Films Ltd

Synapses Neuroscience Limited

 

David has held no other directorships/partnerships in the past five years.
David was a director of Galleon Holdings PLC between March 2006 to October
2013. Galleon Holdings PLC went into administration in August 2013 and was
subject to a Company Voluntary Arrangement in September 2013. There was no
shortfall to creditors.

 

Save as set out above, there is no further information to be disclosed in
relation to David Wong's appointment to the Board pursuant to AIM Rule 17 or
paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

The information contained within this Announcement is deemed by Vulcan Two
Group plc to constitute inside information as stipulated under the Market
Abuse Regulation (EU) No. 596/2014 as it forms part of UK law by virtue of the
European Union (Withdrawal) Act 2018 ("MAR").

 

- Ends -

 

For further information please contact:

 

 Vulcan Two Group plc                                       E: info@vulcantwo.com (mailto:info@vulcantwo.com)

 Susan Clement Davies, Chair

 Michael Kraftman, Chief Executive Officer

 Brendan O'Brien, Chief Operating Officer

 www.vulcantwo.com (http://www.vulcantwo.com)
 Canaccord Genuity Limited                                  Tel: +44 (0) 20 7523 8000

(Nominated Adviser and Sole Broker)

 Simon Bridges / Harry Pardoe / Elizabeth Halley-Stott
 Alma Strategic Communications                              Tel: +44 (0)20 3405 0205

 Justine James / Josh Royston / Sam Modlin / Will Merison   E: vulcantwo@almastrategic.com (mailto:vulcantwo@almastrategic.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOASFFESFEMSEEF



            Copyright 2019 Regulatory News Service, all rights reserved